ICP/MS
IndustriesPharma & Biopharma
ManufacturerShimadzu
Importance of the Topic
The control of toxic elemental impurities in dietary supplements is critical to safeguard consumer health and ensure regulatory compliance. Heavy metals such as arsenic, cadmium, mercury, and lead can pose significant health risks if present above specified limits. The United States Pharmacopeia (USP) 2232 provides guidelines for permitted daily exposure (PDE) levels of these elements, requiring manufacturers and importers to verify that supplement products meet concentration thresholds.
Objectives and Overview of the Study
This application note describes a quantitative analysis of arsenic, cadmium, mercury, and lead in four commercially available dietary supplements. The study aims to demonstrate compliance with USP 2232 limits by converting PDE values into concentration limits and measuring actual levels in tablet formulations using the Shimadzu ICPMS-2030.
Methodology and Sample Preparation
Sample preparation was carried out using closed-vessel microwave digestion to minimize loss of volatile species. Key steps included:
- Weighing one tablet and adding 0.5 mL hydrochloric acid plus 6.5 mL nitric acid into a quartz vessel.
- Applying a six-step microwave program (max. 180 °C, 1000 W) to achieve complete decomposition.
- Diluting digests to 30 mL with ultrapure water.
- Adding internal standards (Ga, In, Bi) at 10 µg/L to correct for instrumental drift.
Instrumentation Used
The Shimadzu ICPMS-2030 was operated under the following conditions:
- RF power: 1.2 kW
- Plasma gas flow: 8.0 L/min; Auxiliary: 1.1 L/min; Carrier: 0.65 L/min
- Nebulizer: Type 10; Cyclone chamber (cooled)
- Mini torch; Collision cell using helium to reduce polyatomic interferences
Main Results and Discussion
Permitted daily exposure and corresponding maximum concentrations for a 10 g/day intake were established (e.g., As: 15 µg/day, 1.5 µg/g). Detection limits ranged from 0.001 to 0.009 µg/L. All four supplement samples showed element levels well below USP thresholds:
- Arsenic: 0.08–0.29 µg/g
- Cadmium: 0.008–0.071 µg/g
- Mercury: not detected
- Lead: 0.009–0.095 µg/g
Spike recovery tests yielded 92–101 % recovery, confirming method accuracy and precision. Sensitivity was sufficient even at the maximum recommended daily intake.
Benefits and Practical Applications
The combination of closed-vessel microwave digestion and collision-cell ICP-MS provides rapid, sensitive, and interference-reduced quantification of toxic elements in complex supplement matrices. This workflow supports pharmaceutical quality control, regulatory submissions, and import/export compliance.
Future Trends and Opportunities
Continued advancements may include:
- Automation of sample preparation and data processing to increase throughput.
- Integration of high-resolution ICP-MS to further minimize spectral overlaps.
- Miniaturized digestion systems to reduce reagent consumption and waste.
- Expanded multi-element screening protocols for comprehensive safety profiling.
Conclusion
This study demonstrates that the Shimadzu ICPMS-2030, combined with microwave digestion, effectively quantifies trace levels of arsenic, cadmium, mercury, and lead in dietary supplements according to USP 2232 requirements, ensuring consumer safety and regulatory compliance.
Reference
USP 2232 Elemental Contaminants in Dietary Supplements
Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.